Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

BIOTRONIK Celebrates 50th Anniversary at Heart Rhythm Congress 2013

Published: Monday, October 21, 2013
Last Updated: Monday, October 21, 2013
Bookmark and Share
Company showcase a number of new innovations.

BIOTRONIK is celebrating its 50th anniversary at Heart Rhythm Congress 2013 by showcasing a number of new innovations.

BIOTRONIK has recently launched an extension of its ProMRI® technology to include full body MR scans for its dual- and single chamber pacemakers.

By combining advanced pacemaker and ICD technology with the option for patients to undergo MR scans, BIOTRONIK is the only company worldwide to allow ICD and heart failure patients (CRT-D and CRT-P) to take advantage of potentially life-saving MR scans.

The DX system
BIOTRONIK’s DX platform, which uses a single lead for complete atrial diagnostics, incorporates the benefits of both single- and dual-chamber ICDs. The DX system provides atrial information to aid in diagnostic accuracy while reducing the risk of complications associated with an additional atrial lead. It also enables early detection of atrial arrhythmia with BIOTRONIK Home Monitoring®.

The DX System - available with the recently FDA-approved Iforia 7 VR-T DX, newly CE marked high energy Idova ICD/CRT-D series and Linoxsmart S DX leads - offers the unique advantages of both single and dual-chamber ICDs.

The use of dual-chamber devices in patients without a clear indication for the use of an additional atrial lead has received a great deal of attention over the past few years. The DX System virtually eliminates this issue, representing a new paradigm in ICD therapy that fills a critical clinical need.

“Throughout our 50-year history, our goal has been to develop the most innovative technology on the market, ensuring physicians and their patients have access to cutting-edge therapies”, said Dr Michael Kipping, Director Sales & Marketing, BIOTRONIK UK & Ireland. “With innovations like ProMRI, DX and CLS we have proven our ability to make a real difference in patients’ lives and live up to our global reputation for excellence.”

Closed Loop Stimulation
CLS Technology - unique to BIOTRONIK pacemakers - is the only sensor system in the world that can trigger changes in heart rate in order to optimize cardiovascular flow not only based on physical activity, but also based on acute mental excitement or stress.

Closed Loop Stimulation is a unique physiologic technology of rate-adaptive pacing. It is the only sensor system in the world that can trigger changes in heart rate to optimize cardiovascular flow during mental excitement or stress.

CLS integrates into the natural cardiovascular control system and determines the appropriate heart rate based on intracardiac impedance measurements. These measurements reflect changes of the cardiac contraction dynamics in reaction to information coming from the autonomic nervous system.

CLS is available for selected BIOTRONIK pacemakers, including ones featuring the original BIOTRONIK Home Monitoring® service.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

FDA Approves First Single-Lead ICD with Atrial Sensing
BIOTRONIK’s Lumax DX system could help the 50,000 patients each year who may benefit from atrial sensing, without pacing indication.
Tuesday, September 17, 2013
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Imaging Software Could Speed Breast Cancer Diagnosis
Technology could improve access to diagnostic services in developing countries.
Data Mining DNA For Polycystic Ovary Syndrome Genes
A new Northwestern Medicine genome-wide association study of PCOS – the first of its kind to focus on women of European ancestry – has provided important new insights into the underlying biology of the disorder.
Algorithm Interprets Breathing Difficulties to Aid in Medical Care
Researchers from North Carolina State University have developed an efficient algorithm that can interpret the wheezing of patients with breathing difficulties to give medical providers information about what’s happening in the lungs.
Researchers Develop qPCR Prognosis Test for NSCLC Patients
A nine-gene molecular prognostic index (MPI) for patients with early-stage non-small cell lung cancer (NSCLC) was able to provide accurate survival stratification and could potentially inform the use of adjuvant therapy in patients struggling with the disease.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!